Compounds > cremophor el
Page last updated: 2024-08-24

cremophor el and Nervous System Diseases

cremophor el has been researched along with Nervous System Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sparreboom, A; van Zuylen, L; Verweij, J1
Gelderblom, H; Nooter, K; Sparreboom, A; Verweij, J1

Reviews

2 review(s) available for cremophor el and Nervous System Diseases

ArticleYear
Role of formulation vehicles in taxane pharmacology.
    Investigational new drugs, 2001, Volume: 19, Issue:2

    Topics: Animals; Anthracyclines; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chemistry, Pharmaceutical; Cyclosporine; Drug Hypersensitivity; Drug Resistance, Multiple; Glycerol; Humans; Micelles; Neoplasms; Nervous System Diseases; Paclitaxel; Polysorbates; Surface-Active Agents

2001
Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation.
    European journal of cancer (Oxford, England : 1990), 2001, Volume: 37, Issue:13

    Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chemistry, Pharmaceutical; Glycerol; Humans; Hyperlipidemias; Lipoproteins; Nervous System Diseases; Surface-Active Agents

2001